Written question asked by Theresa Villiers (Conservative) on Monday, 21 June 2021, in the House of Commons. It was due for an answer on Thursday, 24 June 2021 (named day). A holding answer was provided on Thursday, 24 June 2021. A substantive answer was provided by Nadhim Zahawi (Conservative) on Friday, 25 June 2021 on behalf of the Department of Health and Social Care.
Coronavirus: Vaccination
- Question
-
To ask the Secretary of State for Health and Social Care, if he will commission research to establish whether covid-19 vaccinations work effectively for people who have received kidney transplants.
- Answer
-
As part of the COVID-19 Immunity National Core Study, UK Research and Innovation (UKRI) is providing initial funding of £1.8 million for 12 months towards the OCTAVE study. The OCTAVE study will examine the effectiveness of COVID-19 vaccines in clinically at-risk groups, including patients with certain immunosuppressed conditions, including renal transplant patients.
Public Health England has been monitoring the effectiveness of vaccinations in clinical risk groups including those with immunosuppression.
From the evaluation of the vaccine programme, the data shows that completion of the two dose schedule correlates well with protection from both disease and severe outcomes.
Secondary information
- Type
- Written question
- Reference
- 19514
- Session
- 2021-22
- Subjects
- Kidneys Transplant surgery Research Vaccination Coronavirus
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2021-06-25 14:39:53 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/19514
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/19514
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2021-22/19514